Ormat Signs 20-Year Clean Energy Deal with Switch for Nevada Data Centers
Ormat Technologies signs a 20-year power deal with Switch to supply geothermal and solar energy to Nevada data centers, supporting clean and reliable power for AI growth.
NOTRELOAD AI
Piper Sandler Downgrades Synopsys as AI Chip Shift Creates Headwinds
Piper Sandler downgraded Synopsys to Neutral, citing AI-driven chip industry shifts, risks to its IP business, and a challenging outlook for 2026.
Intel Stock Gets a Boost as Demand for Data Center Chips Surges
KeyBanc upgrades Intel to Overweight with a $60 target, citing strong data center demand, near sell-out of server CPUs, and possible price increases in 2026.
Goldman Sachs Upgrades Arcus Biosciences to Buy on Strong Cancer Drug Data
Goldman Sachs upgraded Arcus Biosciences to Buy, raising its price target to $28 on promising results for its lead cancer drug Casdatifan.
Solid Biosciences Wins FDA Orphan Drug Status for Friedreich's Ataxia Treatment
Solid Biosciences receives FDA Orphan Drug designation for SGT-212, a dual-route gene therapy treating Friedreich's ataxia, with first patient dosed in clinical trial.
Bakkt Acquires DTR: Analyst Sees Strong Growth Ahead
Bakkt agrees to acquire Distributed Technologies Research in $150M stock deal. Clear Street analyst rates it a Buy with $39 target as stablecoin business expands.